Skip to main content
SpringerLink
Log in

Gutartige Brusterkrankungen

  • Chapter
Gynäkologische Endokrinologie und Fortpflanzungsmedizin

  • 67 Accesses

Zusammenfassung

Die klinische Diagnose „Mastopathie“ umfaßt gutartige, mehr oder weniger diffuse Veränderungen der weiblichen Brustdrüse (Verdichtung, Knoten) und damit einhergehende Beschwerden (Mastodynie). Pathologisch-anatomisch findet sich bei klinischer Mastopathie ein buntes Bild histologischer Veränderungen. Neue pathologisch-anatomische Einteilungen differenzieren in erster Linie nach dem Entartungsrisiko.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Ahumada JC, del Castillo EB (1932) Amenorrhea y galactorr- hea. Bol Soc Obstet Ginec of Buenos Aires 11: 64–67

    Google Scholar 

  • Aksu MF, Tzingounis VA, Greenblatt RB (1978) Treatment of benign breast disease with danazol: a follow-up report. J Reprod Med 21: 181–184

    PubMed  CAS  Google Scholar 

  • Andersen AN, Larsen JF, Steenstrup OR, Svendstrup B, Nielsen (1977) Effect of bromocriptine on the premenstrual syndro,:e. A double-blind clinical trial. Br J Obstet Gynaecol 84: 370–374

    Google Scholar 

  • Arabin B, v Fournier D, Kubli F, Müller A, Weber E (1985) Probleme und Grenzen der mammographischen Karzinomdiagnostik: Vergleich der präoperativen radiologischen Diagnose mit dem histologischen Befund bei 335 Patientinnen mit subkutaner Mastektomie. Geburtshilfe Frauenheilkd 45:595–603

    Google Scholar 

  • Argonz J, del Castillo EB (1953) A syndrome characterized by estrogenic insufficiency, galactorrhea, and decreased urinary gonadotropin. J Clin Endocrinol 13: 79

    CAS  Google Scholar 

  • Ariel IM (1973) Enovid therapy (norethynodrel with mestranol) for fibrocystic disease. Am J Obstet Gynecol 117: 453–459

    PubMed  CAS  Google Scholar 

  • Asch RH (1977) The use of an impeded androgen — danazol — in the management of benign breast disorders. Am J Obstet Gynecol 127: 130–134

    PubMed  CAS  Google Scholar 

  • Ashikari R, Huvos GH, Snyder RE, Lucas JC, Hutter RVP, McDivitt RW; Schottenfeld D (1974) A clinicopathologic study of atypical lesions of the breast. Cancer 33: 310–317

    PubMed  CAS  Google Scholar 

  • Atkins HJB (1949) The effect of endocrines on fibroadenosis. Br Med J: 750–752

    Google Scholar 

  • Ayers JWT, Gidwani GP (1983) The „luteal breast“: hormonal and sonographic investigation of benign breast disease in patients with cyclic mastalgia. Fertil Steril 40:779–784

    Google Scholar 

  • Azzopardi JG (1979) Problems in breast pathology. Saunders, London

    Google Scholar 

  • Bässler R, Schulze G, Schriever D (1970) Histochemische Untersuchungen am Bindegewebe der hormonal stimulierten Mamma. Beitr pathol Anat 140: 212–236

    PubMed  Google Scholar 

  • Bässler R (1978) Pathologie der Brustdrüse. In: Dörr W, Seifert G, Uehlinger E (Hrsg) Spezielle pathologische Anatomie, Bd 11. Springer, Berlin Heidelberg New York

    Google Scholar 

  • Bauer M, v Fournier D, Späh U, Kubli F, Jansa J (1982) Behandlungsergebnisse bei der Mastopathie. In: Frischbier HJ (Hrsg) Die Erkrankungen der weiblichen Brustdrüse. Thieme, Stuttgart

    Google Scholar 

  • Bennett IC, McCaffrey JF, McCaffrey E, Wyatt B (1990) Serum oestradiol in women with and without breast disease. Br J Cancer 61: 142–146

    PubMed  CAS  Google Scholar 

  • Berta L, Frairia R, Bumma C, Navello C, Mossetti C, Rovero E, Gaidano G (1983) Hormonal pattern and sex hormone binding globulin in plasma of women with cystic breast disease. In: Angeli A, Bradlow HL, Dogliotti L (eds) Endocrinology of cystic breast disease. Raven, New York, pp 123–126

    Google Scholar 

  • Bischoff J, Rebhan EM, Prestele H, Becker H (1980) Serum-Prolaktin und Anamnesevergleich bei Mammazysten und zystischer Mastopathie. Geburtshilfe Frauenheilkd 40: 65–71

    PubMed  CAS  Google Scholar 

  • Bischoff J, Mulz D, Knüpfer A, Becker H (1981) Therapie vom Mammazysten mit 2-alpha-Bromergokriptin. Geburtshilfe Frauenheilkd 41:635–637

    Google Scholar 

  • Blichert Toft M, Nyboe Andersen A, Henriksen OB, Mygind T (1979) Treatment of mastalgia with bromocriptine: a double-blind cross-over study. Br Med J: 237

    Google Scholar 

  • Bloch K (1961) Zur Pathogenese der Mammahypertrophie bei der Digitalisapplikation. Z Kreislaufforsch 50: 591–595

    CAS  Google Scholar 

  • De Boever J, Verbeugen C, van Maele G, Vandekerckhove D (1983) Steroid concentrations in serum glandular breast tissue, and breast cyst fluid of control and progesterone-treated patients. In: Angeli A, Bradlow HL, Dogliotti L (eds) Endocrinology of cystic breast disease. Raven, New York, pp 93–99

    Google Scholar 

  • Bohnet HG (1981) Prolaktin und seine Bedeutung für die Frau. In: Schirren C, Semm K (Hrsg) Forschritte der Fertilitätsforschung 9. Grosse, Berlin

    Google Scholar 

  • Bohnet HG, Gómez F, Friesen HG (1977) Prolactin and estrogen binding sites in the mammary gland of the lactating and non-lactating rat. Endocrinology 101: 1111–1121

    PubMed  CAS  Google Scholar 

  • Bongiovanni AM (1983) An epidemic of premature thelarche in Puerto Rico. J Pediatr 103: 245–246

    PubMed  CAS  Google Scholar 

  • Brennan MJ, Bulbrook RD, Deshpande N, Wang DY (1973) Urinary and plasma androgens in benign breast disease. Lancet I: 1076–1079

    Google Scholar 

  • Bruning PF, Bonfrèr JMG, Bobrow L, de Jong-Bakker M, Hart AAM, Misdorp W (1984) Plasma hormones in premenopausal women with benign breast disease. In: International Congress, endocrinology of the breast, Torino, Italy. NY Acad Sci (Abstract 102 )

    Google Scholar 

  • Buckle R (1979) Danazol therapy in gynaecomastia; recent experience and indications for therapy. Postgraduate Med J 55 (suppl 5) 71–78

    Google Scholar 

  • Bundred NJ, West RR, O’Dowd J, Mansel RE, Hughes LE (1991) Is there an increased risk of breast cancer in women who have had a breast cyst aspirated? Br J Cancer 64: 953–955

    PubMed  CAS  Google Scholar 

  • Carlström K, Döberl A, Gershagen S, Rannevik G (1984) Peripheral levels of androgens and of some steroid sensitive plasma proteins in patients with fibrocystic breast disease. In: International Congress, endocrinology of the breast, Torino, Italy. NY Acad Sci (Abstract 103 )

    Google Scholar 

  • Chiari J (1852) Anomalien der Größe. In: Klinik der Geburtshilfe and Gynäkologie. Enke, Erlangen

    Google Scholar 

  • Cole EN, Sellwood RA, England PC, Griffiths K (1977) Serum prolactin concentrations in benign breast disease throughout the menstrual cycle. Eur J Cancer 13: 597–603

    PubMed  CAS  Google Scholar 

  • Colin C, Gaspard U, Lambotte R (1978) Relationship of mastodynia with its endocrine environment and treatment in a double blind trial with lynestrenol. Arch Gynäkol 225: 7–13

    PubMed  CAS  Google Scholar 

  • D’Agata R, Aliffi A, Maugeri G, Mongioi A, Vicari E; Gulizia S (1982) Dynamics of Prl release in galactorrhoeic normoprolactinaemic women. Acta Endocrinol 101: 1–4

    PubMed  Google Scholar 

  • Davajan V, Kletzky O, March ChM, Roy S, Mishell DR jr (1978) The significance of galactorrhea in patients with normal menses, oligomenorrhea, and secondary amenorrhea. Am J Obstet Gynecol 130: 894–904

    PubMed  CAS  Google Scholar 

  • Dershaw DD (1986) Male mammography. Amer J Roent 145: 127–131

    Google Scholar 

  • Dhont M, Delbeke L, Van Eyck J, Voorhoof L (1979) Danazol treatment of chronic cystic mastopathy; a clinical and hormonal evaluation. Postgrad Med J 55: 66–70

    PubMed  Google Scholar 

  • Dupont WD, Page DL (1985) Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med 312: 146–151

    PubMed  CAS  Google Scholar 

  • Dupont WD, Page DL, Rogers LW, Parl FF (1989) Influence of Exogenous Estrogens, Proliferative Breast Disease, and Other Variables on Breast Cancer Risk. Cancer 63: 948–957

    Google Scholar 

  • Dupont WD, Page DL (1989) Relative Risk of Breast Cancer Varies With Time Since Diagnosis of Atypical Hyperplasia. Hum Pathol 20: 723–725

    PubMed  CAS  Google Scholar 

  • Durning P, Sellwood RA (1982) Bromocriptine in severe cyclical breast pain. Br J Surg 69: 248–249

    PubMed  CAS  Google Scholar 

  • Eberle AJ, Sparrow JT, Keenan BS (1986) Treatment of persistent pubertal gynaecomastia with dihydrotestosterone heptanoate. J of Pediatrics 109: 144–149

    CAS  Google Scholar 

  • England PC, Skinner LG, Cottrell KM, Sellwood RA (1974) Serum oestradiol-17ß in women with benign and malignant breast disease. Br J Cancer 30: 571–576

    PubMed  CAS  Google Scholar 

  • Ernster VL (1981) The epidemiology of benign breast disease. Epidemiol Rev 3: 184–202

    PubMed  CAS  Google Scholar 

  • Ernster VL, Goodson WH, Hunt TK, Petrakis NL, Sickles EA; Miike R (1985) Vita…_ E……. ~ (1985) visa E and benign breast „discasc“: A double-blind, randomized clinical trial. Surgery 97: 490–494

    Google Scholar 

  • Ernster VL, Wrensch MR, Petrakis NL, King EB; Miike R, Murai J, Goodson WH, Siiteri PK (1987) Benign and Malignant Breast Disease: Initial Study Results of Serum and Breast Fluid Analyses of Endogenous Estrogens. JNCI 79: 949–960

    Google Scholar 

  • Eversmann T, Moito J, von Werder K (1984) Testosteron-and Östradiospiegel bei der Gynäkomastie des Mannes. Dtsch Med Wschr 109: 1678–1682

    PubMed  CAS  Google Scholar 

  • Fara GM, Del Corvo G, Bernuzzi S et al. (1979) Epidemic of breast enlargement in an Italian school. Lancet ii: 295–297

    Google Scholar 

  • Fentiman IS, Caleffi M, Brame K, Chaudary MA, Hayward JL (1986) Double-blind controlled trial of tamoxifen therapy for mastalgia. Lancet I: 287–288

    Google Scholar 

  • Ferenczy A (1979) Proliferation kinetics of human endometrium during the normal menstrual cycle. Am J Obstet Gynecol 133: 859–867

    PubMed  CAS  Google Scholar 

  • Ferguson DJP, Anderson TJ (1981) Morphological evaluation of cell turnover in relation to the menstrual cycle in the „resting“ human breast. Br J Cancer 44: 177–181

    PubMed  CAS  Google Scholar 

  • Forbes AP, Hennemann PH, Griswold GC, Albright F (1954) Syndrome characterized by galactorrhea, and low urinary FSH: Comparison with acromegaly and normal lactation. J Clin Endocrinol 14: 265

    Google Scholar 

  • von Fournier D, Kubli F, Junkermann H, Bauer M, Legler U, Arabin B, Müller A (1984) Medikamentöse and operative Therapie der Mastopathie in Abhängigkeit vom Entartungsrisiko. Frauenarzt 4: 27–39

    Google Scholar 

  • Frantz VK, Pickren JW, Melcher GW, Auchincloss H Jr (1951) Incidence of chronic cystic disease in so-called “normal breasts:’ A study based on 255 postmortem examinations. Cancer 4: 762–783

    PubMed  CAS  Google Scholar 

  • Frommel R (1882) Über puerperale Atrophie des Uterus. Z Geburtsh Gynäkol 7: 305–318

    Google Scholar 

  • Fuerst CJ, Lundell M, Ahlbaeck SO, Holm LE (1989) Breast hypoplasia following irradiation of the female breast in infancy and early childhood. Acta Oncol 28 (4): 519–523

    Google Scholar 

  • Gangemi M, Velasco M, Graziottin A, Licori D, Marchesoni D (1981) Bromoergocriptin therapy in eumenorrhoic patients presenting galactorrhea. Clin Exp Obstet Gynaecol 2: 79–82

    Google Scholar 

  • Geschickter ChF (1948) Diseases of the breast; diagnosis, pathology, treatment, 2nd edn. Lippincott, Philadelphia

    Google Scholar 

  • Geschickter ChF, Hartman CG (1959) Mammary response to prolonged estrogenic stimulation in the monkey. Cancer 12:767–781

    Google Scholar 

  • Goebel R (1984) Results of the clinical evaluation of danazol in benign breast disease compared with local treatment, gesta-gens and bromocriptine. In: Baum M, George WD, Hughes LE (eds) Benign breast disease. The Royal Society of Medicine, London 76: 115–120

    Google Scholar 

  • Goebel R, Junkermann H, von Fournier D (1989) Danazoltherapie bei gutartigen Brusterkrankungen. Gynäkologe 22: 262–270

    PubMed  CAS  Google Scholar 

  • Gorins A, Cordray JP (1984) Hormonal profile of benign breast disease and premenstrual mastodynia. Eur J Gynaecol On-col 1: 1–10

    Google Scholar 

  • Grattarola R (1978) Anovulation and increased androgenic activity as breast cancer risk in women with fibrocystic disease of the breast. Cancer Res 38: 3051–3054

    Google Scholar 

  • Graziottin A, Sopracordevole F, Velasco M, Grella PV (1984) Plasma prolactin in women with mastodynia. Clin Exp Ob-stet Gynecol 3: 113–115

    Google Scholar 

  • Greenblatt RB, Dmowski WP, Mahesh VB, Scholer HFL (1971) Clinical Studies with an antigonadotrophin — Danazol. Ferai Sernut wiu 22: 102–112

    CAS  Google Scholar 

  • Greenblatt B, Ben-Nun I (1980) Danazol in the treatment of mammary dysplasia. Drugs 19: 349–355

    PubMed  CAS  Google Scholar 

  • Haagensen CD (1971) Diseases of the breast, 2nd edn. Saunders, Philadelphia

    Google Scholar 

  • Haagensen CD, Bodian C, Haagensen DE Jr (1981) Breast carcinoma: risk and detection. Saunders, Philadelphia

    Google Scholar 

  • Hammond GL, Nisker JA, Jones LA, Siiteri PK (1980) Estimation of the percentage of free steroid in undiluted serum by centrifugal ultrafiltration-dialysis. J Biol Chem 11:5023–5026

    Google Scholar 

  • Hedberg K, Karlsson K, Lindstedt G (1979) Gigantomastia during pregnancy: Effect of a dopamine agonist. Am J Obstet Gynecol 133: 928–931

    Google Scholar 

  • Heywang SH, Wolf A, Pruss E, Hilbertz T, Eiermann W, Permanetter W (1989) MR Imaging of the breast with GdDTPA: Use and Limitations. Radiology 171: 95–103

    Google Scholar 

  • Hinton CP, Williams MR, Roebuck EJ, Blarney RW (1986) A controlled trial of danazol in the treatment of multiple recurrent breast cysts. Br J Clin Pract 40: 368–370

    PubMed  CAS  Google Scholar 

  • Hooper PD (1985) Puberty gynaecomastia. J of the Royal College of General Practitioners 35: 142

    CAS  Google Scholar 

  • Hughes LE, Mansel RE, Webster DJT (1989) Benign Disorders and Diseases of the Breast: Concepts and Clinical Management. Ballière Tindall, London Philadelphia Toronto Sydney Tokyo

    Google Scholar 

  • Ingram DM, Nottage EM, Willcox DL, Roberts A (1990) Oestrogen binding and risk factors for breast cancer. Br J Cancer 61 (2): 303–307

    PubMed  CAS  Google Scholar 

  • Jeffreys DB (1979) Painful gynaecomastia treated with tamoxifen. Brit Med J i: 1119–1120

    Google Scholar 

  • Jensen RA, Page DL, Dupont WD, Rogers LW (1989) Invasive Breast Cancer Risk in Women With Sclerosing Adenosis. Cancer 64: 1977–1983

    PubMed  CAS  Google Scholar 

  • Jones JR, Gentile GP (1975) Incidence of galactorrhea in ovula- tory and anovulatory females. Obstet Gynecol 45: 13–14

    PubMed  CAS  Google Scholar 

  • Junkerman H, Klinga K, Weber E, von Fournier D (1989) Endocrinology of Benign Breast Disease in Relation to the Severity of Radiological Dysplasia. Horm Res 32 (suppl 1): 10–14

    Google Scholar 

  • Junkermann H, Anton H-W, Krapfl E, Harcos A, von Fournier D (1993) Abklärung von Mammaläsionen durch Stanz-, Drill-, und Feinnadelbiopsie. Radiologe 33: 267–270

    Google Scholar 

  • Kaiser R (1969) Zur Ätiologie und Prophylaxe des Endometriumkarzinoms. Geburtshilfe Frauenheilkd 29: 431

    PubMed  CAS  Google Scholar 

  • Kaiser WA, Diedrich K, Reiser M, Krebs D (1993) Moderne Diagnostik der Mamma. Geburtshilfe und Frauenheilkunde 53: 1–14

    PubMed  CAS  Google Scholar 

  • Kleinberg DL, Noel GL, Frantz AG (1977) Galactorrhea: a study of 235 cases, including 48 with pituitary tumors. N Engl J Med 296: 589–600

    PubMed  CAS  Google Scholar 

  • Knitza R, Eiermann W, Wisser J, Huber B (1989) Schwangerschaftsinduzierte Gigantomastie. Geburtsh und Frauenheilk 49: 915–916

    CAS  Google Scholar 

  • Kolodny RC, Jacobs LS, Daughaday WH (1972) Mammary stimulation causes prolactin secretion in non-lactating women. Nature 238: 284–286

    PubMed  CAS  Google Scholar 

  • Kramer WM, Rush RF (1973) Mammary duct proliferation in the elderly. Cancer 31: 130–137

    PubMed  CAS  Google Scholar 

  • Kubista E, Müller G, Spona J (1984) Treatment of painful mastopathy. A prospective randomized trial. In: International congress, endocrinology of the breast. Torino, Italy. NY Acad Sci (Abstract 120 )

    Google Scholar 

  • Kullander S (1976) Effect of 2 Br-alpha-ergocryptin (CB 154) on serum prolactin and the clinical picture in a case of progressive gigantomastia in pregnancy. Ann Chir Gynecol Fenn 65: 227

    CAS  Google Scholar 

  • Kumar S, Mansel RE, Hughes LE, Woodhead JS, Edwards CA, Scanlon MF, Newcombe RG (1984) Prolactine response to thyrotropin-releasing hormone stimulation and dopaminergic inhibition in benign breast disease. Cancer 53: 1311–1315

    PubMed  CAS  Google Scholar 

  • Lang WR, Renwick S, Johnson L, Wyse E (1972) Benign mammary dysplasia. Med J Aust 2: 147–149

    PubMed  CAS  Google Scholar 

  • Lauersen NH, Wilson KG (1976) The effect of danazol in the treatment of chronic cystic mastitis. Obstet Gynecol 48: 93–98

    PubMed  CAS  Google Scholar 

  • Lauritzen C (1990) Hormonelle Substitutionstherapie zur Brustvergrößerung. Curation 39–41

    Google Scholar 

  • Leucht W, Rabe D, Boos R, Humbert KD, v. Fournier D, Schmidt W (1984) Stellenwert der hochauflösenden RealTime-Sonographie beim Mammakarzinom. Geburtshilfe Frauenheilkd 44: 557–562

    CAS  Google Scholar 

  • LiVolsi VA, Stadel BV, Kelsey JL, Holford TR, White C (1978) Fibrocystic breast disease in oral-contraceptive users. A histopathological evaluation of epithelial atypia. N Engl J Med 299: 381–385

    Google Scholar 

  • Mancini AM, Aparicio NJ, Vargas DA, Debeljuk L, Guitelman A (1978) Serum levels of prolactin under basal conditions and after administration of sulpiride in normal and galactorrheic women. Fertil Steril 29: 459–461

    PubMed  CAS  Google Scholar 

  • Mansel RE, Dogliotti L (1990) European multicentre trial of bromocriptine in cyclical mastalgia. Lancet 335: 190–193

    PubMed  CAS  Google Scholar 

  • Mansel RE, Preece PE, Hughes LE (1980) Treatment of cyclical breast pain with bromocriptine. Scott Med J 25: 65–70

    Google Scholar 

  • Mansel RE, Wisbey JR, Hughes LE (1982) Controlled trial of the antigonadotropin danazol in painful nodular benign breast disease. Lancet 1: 928–930

    PubMed  CAS  Google Scholar 

  • Mansel RE (1989) Goserelin — the British multicentre trial. Br J Clin Pract 43, Suppl 68: 33

    CAS  Google Scholar 

  • McDivitt RW, Rubin GL, Stevens JA, Wingo PA (1988) Lab Invest 58: 62A

    Google Scholar 

  • Martin PM, Kuttenn F, Serment H, Mauvais-Jarvis P (1978) Studies on clinical hormonal and pathological correlations in breast fibroadenomas. J Steroid Biochem 9: 1251–1255

    PubMed  CAS  Google Scholar 

  • Masters JRW, Drife JO, Scarisbrick JJ (1977) Cyclic variation of DNA synthesis in human and breast epithelium. JNCI 58:1263–1265

    Google Scholar 

  • Mauvais-Jarvis P, Kuttenn F, Ohlgiesser C (1974)(Résultats du traitement des mastodynies et des mastopathies par la progestérone percutanée. Nouv Presse Mèd 16: 1027–1028

    Google Scholar 

  • Minton JP, Abou-Issa H, Reiches N, Roseman JM (1981) Clinical and biochemical studies on methylxanthine-related fibrocystic breast disease. Surgery 90: 299–304

    PubMed  CAS  Google Scholar 

  • Moore JW, Clark GMG, Bulbrook RD, Hayward JL, Murai JT, Hammond GL, Siiteri PK (1982) Serum concentrations of total and non-protein-bound oestradiol in patients with breast cancer and in normal controls. Int J Cancer 29: 17–21

    PubMed  CAS  Google Scholar 

  • Moore DC, IT Schlaepfer L, Paunier L, Sizonenko PC (1984) Hormonal changes during puberty vs transient pubertal gynaecomastia and abnormal androgen estrogen ratios. J Clin Endocr Metabol 58: 492–499

    CAS  Google Scholar 

  • Mortola JF, Girton L, Fischer U (1991) Successful treatment of severe premenstrual syndrome by combined use of gonatotropin-releasing hormone agonist and estrogen/progestin. J Clin Endocrinol Metab 72: 252A - 252F

    PubMed  CAS  Google Scholar 

  • Mühlenstedt D, Böttcher HD, Osmers F (1983) Endokrinologisch-radiologische Aspekte der Galaktorrhö. Medwelt 34:302–307

    Google Scholar 

  • Myhre SA, Ruvalcaba RHA, Johnson HR, Thuline HC, Kelley VC (1970) The effects of testosterone treatment in Klinefelter’s syndrome. J Pediatr 76: 267–276

    PubMed  CAS  Google Scholar 

  • Noel GL, Suh HK, Frantz AG (1974) Prolactin release during nursing and breast stimulation in postpartum and nonpostpartum subjects. J Clin Endocrinol Metab 38: 413–423

    PubMed  CAS  Google Scholar 

  • Nordquist S (1970) The synthesis of DNA and RNA in normal human endometrium in shortterm incubation in vitro and its response to oestradiol and progesterone. J Endocrinol 48: 17–28

    Google Scholar 

  • Nuttall FQ (1979) Gynaecomastia as a physical finding in normal men. J Clin Endocr Metabol 48: 338–340

    CAS  Google Scholar 

  • Nydick M, Bustos J, Dale JH, Rawson RW (1961) Gynaecomastia in adolescent boys. J Amer Med Assoc 178: 449–457

    CAS  Google Scholar 

  • Nyirjesy I (1968) Galactorrhea without amenorrhea. Obstet Gynecol 32: 52–57

    PubMed  CAS  Google Scholar 

  • Ouimet-Oliva D, van Campenhout J, Hébert G, Ladouceur J (1981) Effect of danazol on the radiographic density of breast parenchyma. J Can Assoc Radiol 32: 159–161

    PubMed  CAS  Google Scholar 

  • Parker LN, Gray DR, Lai MK, Levin ER (1986) Treatment of gynectomastia with tamoxifen: A double blind cross-over study. Metabolism 35: 705–708

    Google Scholar 

  • Parlati E, Travaglini A, Liberale I, Menini E, Dell’Acqua S (1988) Hormonal profile in benign breast disease. Endocrine status of cyclical mastalgia patients. J Endocrinol Invest 11 (9): 679–683

    PubMed  CAS  Google Scholar 

  • Pashby NL, Mansel RE, Hughes LE, Hanslip J, Preece PE (1981) A clinical trial of evening primrose oil in mastalgia. British Journal of Surgery 68: 801

    Google Scholar 

  • Peters F (1991) Gutartige Erkrankungen der Brust: Leitfaden für die Praxis. Urban & Schwarzenberg, München

    Google Scholar 

  • Peters F (1992) Multicentre study of gestrinone in cyclical breast pain. Lancet 339: 205–208

    PubMed  CAS  Google Scholar 

  • Peters F, Pickardt CR, Breckwoldt M (1983) Hormonal status of women with benign cystic breast disease: clinical implications. In: Angeli A, Bradlow HL, Dogliotti L (eds) Endocrinology of cystic breast disease. Raven, New York, pp 113–122

    Google Scholar 

  • Petrakis NL, Mason L, Lee R, Sugimoto B, Pawson S, Catchpool F (1975) Association of race, age, menopausal status, and cerumen type with breast fluid secretion in nonlactating women, as determined by nipple aspiration. JNC1 54:829–833

    Google Scholar 

  • Preece PE (1989) Medical Treatment of Benign Breast Disease. In: Kubli F, von Fournier D, Junkermann H, Bauer M, Kaufmann M (eds) Breast Diseases. Springer, Berlin Heidelberg New York, pp 507–512

    Google Scholar 

  • Preece PE, Richards AR, Owen GM, Hughes LE (1975) Mastalgia and total body water. Br Med J 4: 498–500

    PubMed  CAS  Google Scholar 

  • Preece PE, Baum M, Mansel RE, Webster DJT, Fortt RW, Gravelle IH, Hughes LE (1982) Importance of mastalgia in operable breast cancer. Br Med J 284: 1299–1300

    CAS  Google Scholar 

  • Rannevik G, Döberl A, Gershagen S, Rasmussen Th, Tobiassen T (1983) Elevated serum concentrations of sex hormone binding globulin in fibrocystic breast disease. In: Angeli A, Bradlow HL, Dogliotti L (eds) Endocrinology of cystic breast disease. Raven, New York, pp 127–134

    Google Scholar 

  • Rasmussen Th, Döberl A, Rannevik G, Tobiassen T (1984) The Hjerring project on fibrocystic breast disease. In: Baum M, George WD, Hughes LE (eds) Benign breast disease. The Royal Society of Medicine, London, 76: 135–1329

    Google Scholar 

  • Reed MJ (1983) Plasma levels of estrone, estrone sulfate, and estradiol and the percentage of unbound estradiol in postmenopausal women with and without breast disease. Cancer Res 43: 3940–3942

    PubMed  CAS  Google Scholar 

  • Richardson MR, Njemanze J (1990) Management of severe fibrocystic disease of the breast with leuprolide acetate. Fertil Steril 54: 942–943

    PubMed  CAS  Google Scholar 

  • Ricciardi I, Ianniruberto A (1979) Tamoxifen-Induced Regression of Benign Breast Lesions. Obstet Gynecol 54:80–84 fluid prolactin and estrogen levels in healthy Finnish and American women and patients with fibrocystic disease. Cancer 57: 1550–1554

    Google Scholar 

  • Saftlas AF, Wolfe JN, Hoover RN, Brinton LA, Schairer C, Salane M, Szklo M (1989) Mammographic parenchymal patterns as indicators of breast cancer risk. Am J Epidemiol 129 (3): 518–526

    PubMed  CAS  Google Scholar 

  • Saftlas AF, Hoover RN, Brinton LA, Szklo M, Olson DR, Salane M, Wolfe JN (1991) Mammographic Densities and Risk of Breast Cancer. Cancer 67: 2833–2838

    PubMed  CAS  Google Scholar 

  • Schulz KD, Del Pozo E, Lose KH, Künzig HJ, Geiger W (1975) Successful treatment of mastodynia with the prolactin inhibitor bromocryptine (CB 154). Arch Gynäkol 220: 83–87

    PubMed  CAS  Google Scholar 

  • Secreto G, Recchione C, Fariselli G, Di Pietro S (1984) High testosterone and low progesterone circulating levels in premenopausal patients with hyperplasia and cancer of the breast. Cancer Res 44: 841–844

    PubMed  CAS  Google Scholar 

  • Sitruk-Ware LR, Sterkers N, Mowszowicz I, Mauvais-Jarvis P (1977) Inadequate corpus luteal function in women with be-sign breast diseases. J Clin Endocrinol Metab 44: 771–774

    PubMed  CAS  Google Scholar 

  • Strömbeck JO (1964) Macromastia in Women and its Surgical Treatment. Acta Chir Scand (Suppl 341), Stockholm

    Google Scholar 

  • Sundaram GS, London R, Margolis S, Wenk R, Lustgarten J, Nair PP, Goldstein P (1981) Serum hormones and lipoproteins in benign breast disease. Cancer Res 41: 3814–3816

    PubMed  CAS  Google Scholar 

  • Swoboda W, Turnheim E, Frisch H, Spona J (1977) Ein neues „Antigonadotropin“ in der Behandlung der Pubertas praecox und der Pubertätsgynäkomastie. Pädiat Pädol (Suppl)5: 109–120

    Google Scholar 

  • Tabar L, Dean PB (1982) Mammographic parenchymal patterns. Risk indicator for breast cancer? JAMA 247: 185–1890

    PubMed  CAS  Google Scholar 

  • Tarquini B, Benvenuti M, Legnaioli M, Bazzani M, Cagnoni M, Halberg F (1981) Mammary cancer risk: circulating TSH and prolactin fibrocystic breast disease in chronoepidemiologic perspective. Cancer Detec Prey 4: 525–534

    CAS  Google Scholar 

  • Taylor PJ, Cumming DC, Corenblum B (1981) Successful treatment of D-penicillamine-induced breast gigantism with danazol. Br Med J 282: 362–363

    CAS  Google Scholar 

  • Teubner J, Junkermann H, van Kaick G, Pickenhan L, Wesch H, Eggert-Kruse W, v. Fournier D, Kubli F (1984) Diagnostische Wertigkeit der Mammasonographie bei Anwendung eines linearen 5 MHZ-Realtime-Scanners (LS 3000, Fa. Picker). Ergebnisse einer prospektiven Studie. In: Lutz H, Reichel L (Hrsg) Ultraschalldiagnostik 83. Thieme, Stuttgart, S 89–92

    Google Scholar 

  • Thomas BS, Kirby P, Symes EK, Wang DY (1976) Plasma dehydroepiandrosterone concentration in normal women and in patients with benign and malignant breast disease. Eur J Cancer 12: 405–409

    PubMed  CAS  Google Scholar 

  • Vetter L, Kraner F, Wyss H (1974) Galactorrhea. Arch Gynecol 216: 81–90

    CAS  Google Scholar 

  • Walsh PV, Morris K, McDicken IW, Whitehouse GN, George WD (1984) Luteal phase function and benign breast disease. In: Baum M, George WD, Hughes LE (eds) Benign breast disease. The Royal Society of Medicine, London, pp 53–62

    Google Scholar 

  • Wang DY, Hayward JL, Bulbrook RD (1966) Testosterone levels in the plasma of normal women and patients with benign breast disease or with breast cancer. Eur J Cancer 2: 373–376

    PubMed  CAS  Google Scholar 

  • Warner E, Lockwood G, Math M, Tritchler D, Boyd NF (1992) The Risk of Breast Cancer Associated with Mammographic Parenchymal Patterns: A Meta-Analysis of the Published Literature to Examine the Effect of Method of Classification. Cancer Detection and Prevention 16: 67–72

    Google Scholar 

  • Watt-Boolsen S, Andersen AN, Blichert-Toft M (1981) Serum prolactin and oestradiol levels in women with cyclical mastalgia. Horm Metab Res 13: 700–702

    PubMed  CAS  Google Scholar 

  • Winchester DP (1986) ACP consensus statement. The relationship of fibrocystic disease to breast cancer. Am Coll Surg Bull 71: 29–31

    Google Scholar 

  • Wolfe JN (1976) Risk for breast cancer development determined by mammographic parenchymal pattern. Cancer 37: 2486–2492

    PubMed  CAS  Google Scholar 

  • Wynder EL, Hill P, Laakso K, Littner R, Kettunen K (1981) Breast Secretion in Finnish women: a metabolic-epidemiologic study. Cancer 47: 1444–1450

    PubMed  CAS  Google Scholar 

Download references

Authors
  1. H. Junkermann
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 1994 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Junkermann, H. (1994). Gutartige Brusterkrankungen. In: Gynäkologische Endokrinologie und Fortpflanzungsmedizin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-07635-4_16

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-07635-4_16

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-07636-1

  • Online ISBN: 978-3-662-07635-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation